These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32240838)

  • 1. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease.
    Chen Q; Li Q; Li D; Chen X; Liu Z; Hu G; Wang J; Ling W
    Atherosclerosis; 2020 Apr; 299():45-52. PubMed ID: 32240838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk.
    Delgado GE; Kleber ME; Moissl AP; Yazdani B; Kusnik A; Ebert MP; März W; Krämer BK; Lammert A; Teufel A
    Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G252-G261. PubMed ID: 34132110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores.
    Tsai TY; Hsu PF; Wu CH; Huang SS; Chan WL; Lin SJ; Chen JW; Lu TM; Leu HB
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis scores predict liver disease mortality in the United States population.
    Unalp-Arida A; Ruhl CE
    Hepatology; 2017 Jul; 66(1):84-95. PubMed ID: 28195363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease.
    Lu C; Chen Y; Zhang Y; Zhao X
    Diabetes Metab Syndr Obes; 2023; 16():2627-2637. PubMed ID: 37663203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.
    Treeprasertsuk S; Björnsson E; Enders F; Suwanwalaikorn S; Lindor KD
    World J Gastroenterol; 2013 Feb; 19(8):1219-29. PubMed ID: 23482703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention.
    Liu HH; Cao YX; Jin JL; Hua Q; Li YF; Guo YL; Zhu CG; Wu NQ; Gao RL; Li JJ
    J Am Heart Assoc; 2021 Feb; 10(3):e018869. PubMed ID: 33506689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.
    Vinikoor MJ; Sinkala E; Mweemba A; Zanolini A; Mulenga L; Sikazwe I; Fried MW; Eron JJ; Wandeler G; Chi BH
    Liver Int; 2015 Jul; 35(7):1886-92. PubMed ID: 25581487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nonalcoholic Fatty Liver Disease Fibrosis Score Is Related to Epicardial Fat Thickness and Complexity of Coronary Artery Disease.
    Turan Y
    Angiology; 2020 Jan; 71(1):77-82. PubMed ID: 31018673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fibrosis markers and all cause mortality in people with type 2 diabetes: A population based study (The Ayrshire Diabetes Outcomes Cohort (ADOC) Study).
    Collier A; Curran C; Cameron L; Wild SH; Byrne CD
    Diabetes Obes Metab; 2023 Sep; 25(9):2659-2668. PubMed ID: 37311724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
    Önnerhag K; Hartman H; Nilsson PM; Lindgren S
    Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
    [No Abstract]   [Full Text] [Related]  

  • 13. The Predictive Value of Time-Varying Noninvasive Scores on Long-Term Prognosis of NAFLD in South Korea.
    Chung SW; Park MK; Zhang X; Wang T; Jemielita T; Fernandes G; Engel SS; Jang H; Lee YB; Cho EJ; Lee JH; Yu SJ; Yoon JH; Kim YJ
    Can J Gastroenterol Hepatol; 2024; 2024():5667986. PubMed ID: 39314528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease.
    Song DS; Chang UI; Kang SG; Song SW; Yang JM
    Gut Liver; 2019 Nov; 13(6):658-668. PubMed ID: 30970434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
    Yue W; Li Y; Geng J; Wang P; Zhang L
    Medicine (Baltimore); 2019 Dec; 98(49):e18038. PubMed ID: 31804310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
    Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C
    Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease.
    Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Cui CJ; Liu G; Sun J; Dong Q; Li JJ
    Hepatol Int; 2021 Apr; 15(2):413-423. PubMed ID: 33740211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage.
    Siddiqui MS; Yamada G; Vuppalanchi R; Van Natta M; Loomba R; Guy C; Brandman D; Tonascia J; Chalasani N; Neuschwander-Tetri B; Sanyal AJ;
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1877-1885.e5. PubMed ID: 30616027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests.
    Bertrais S; Boursier J; Ducancelle A; Oberti F; Fouchard-Hubert I; Moal V; Calès P
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1240-1249. PubMed ID: 27897323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.